About
About The Evidence Base®
The Evidence Base® is a free-to-access online hub providing the latest news, opinions and insights into hot topics including real-world data, health economics and outcomes research, and much more.
Through partnership with the Journal of Comparative Effectiveness Research, we seek to educate and inspire to help this exciting field move forward at an even faster rate.
About the Journal
The peer-reviewed Journal of Comparative Effectiveness Research (ISSN: 2042-6305) provides a rapid-publication platform for debate and the presentation of new findings and research methodologies.
Through rigorous evaluation and comprehensive coverage, the Journal of Comparative Effectiveness Research provides stakeholders – including patients, clinicians, healthcare purchasers and health policy makers – with the key data and opinions to make informed and specific decisions on clinical practice.
Registered members of The Evidence Base have free access to select content from the Journal of Comparative Effectiveness Research.
Articles published in the Journal of Comparative Effectiveness Research cover key areas such as:
- Studies of patient-centered outcomes, effectiveness or comparative effectiveness yielding new findings relating to diagnostics, therapeutics, surgical procedures, or other healthcare services or options
- Systematic reviews of available evidence relating to the pros and cons of healthcare options for specific patient groups, including precision medicine and comparative safety
- Perspectives and debate relating to the methodology of comparative effectiveness studies and best practice issues
- Commentary on both patient-relevant outcomes and economic implications
- Real-world evidence assessing the comparative safety and effectiveness of existing and new treatment strategies
- Direct ‘head-to-head’ comparisons of available diagnostic and therapeutic options – evaluating the performance of clinical alternatives against current standards of care
- Evaluation and interpretation of the findings of recently completed comparative effectiveness trials, as well as articles discussing the design and rationale of newly commenced studies
- Pharmacoeconomic, health economics and outcomes research studies
For more details, please see here or contact the journal’s Editor, Laura Dormer.
About Becaris Publishing Limited
Real-world evidence (RWE) is now accepted by a wide range of stakeholders to support decision making across the pharmaceutical product lifecycle as well as in clinical practice to provide true patient-centric care. Real-world data (RWD), and the evidence generated by analyzing this data, serves to complement, or even broaden, the data derived from clinical trials. From identifying unmet patient needs to learning more about how treatments are used in real life, RWE can guide the development of new therapies, support regulatory approvals and inform treatment strategies. Use of RWE and big data offers the potential to harness vast amounts of medical data, but also brings significant methodological, legal and ethical challenges.
Becaris Publishing is dedicated to this space by providing accessible and trusted, evidence-based information across the RWE spectrum. The Journal of Comparative Effectiveness Research publishes the latest peer-reviewed, open access research and opinion written by leading experts in the field. Complementing the journal, The Evidence Base® curates news, opinion, multimedia content and more in an online forum to enable a wider audience to learn about the latest developments in the application, discussion, research and debate around RWE.
For more information, visit www.becarispublishing.com.
Disclaimer
The opinions expressed on The Evidence Base are those of the authors/interviewees and do not necessarily reflect the views of The Evidence Base, Becaris Publishing Limited or any of its affiliates.
